$10.38 0.0 0.0%
Last Trade - 15/04/21
| Market Cap | £42.0m |
| Enterprise Value | £33.2m |
| Revenue | £5.50m |
| Position in Universe | 5533rd / 6851 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.69 | 1.10 | 1.56 | 2.44 | 3.84 | 7.58 | 11.7 | 17.0 | +61.5% | ||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Myomo, Inc. is a United States-based medical device company specializing in myoelectric orthotics for people with neurological disorders. The Company’s products help to restore function in individuals with neuromuscular conditions, such as brachial plexus injury, spinal cord injury, multiple sclerosis and stroke. Its MyoPro myoelectric limb orthosis is a powered brace that supports a weakened and deformed arm for functional use. The MyoPro is an elbow/wrist/Hand orthosis, which supports the arm and helps to bend and straighten the arm at the elbow. The brace provides assistive function for joint motion that enables a user to self-initiate and control movements of a partially paralyzed arm using their own muscle signals. When the user tries to bend their arm, sensors in the brace detect the weak muscle signal, which activates the motor to amplify their weak muscle signal to help bend and move their arm. The brace uses non-invasive skin sensors.
| Last Annual | December 31st, 2020 |
| Last Interim | December 31st, 2020 |
| Incorporated | September 1, 2004 |
| Public Since | June 12, 2017 |
| No. of Shareholders: | 130 |
| No. of Employees: | 62 |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Supplies |
| Index | |
| Exchange | NYSE MKT |
| Shares in Issue | 5,582,870 |
| Free Float | (0.0%) |
| Eligible for |
✓
ISAs
✓
SIPPs
|
| Address | 137 PORTLAND STREET 4TH FLOOR, BOSTON, 02114, United States |
| Web | http://myomo.com/ |
| Phone | +1 617 9969058 |
| Contact | () |
| Auditors | Marcum LLP |
As of 15/04/21, shares in Myomo Inc are trading at $10.38, giving the company a market capitalisation of £42.0m. This share price information is delayed by 15 minutes.
Shares in Myomo Inc are currently trading at $10.38 and the price has moved by 0.166k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Myomo Inc price has moved by 80.65% over the past year.
Of the analysts with advisory recommendations for Myomo Inc, there are there are currently 1 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Myomo Inc is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Myomo Inc is scheduled to issue upcoming financial results on the following dates:
Myomo Inc does not currently pay a dividend.
Myomo Inc does not currently pay a dividend.
Myomo Inc does not currently pay a dividend.
To buy shares in Myomo Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Myomo Inc are currently trading at $10.38, giving the company a market capitalisation of £42.0m.
Here are the trading details for Myomo Inc:
Based on an overall assessment of its quality, value and momentum, Myomo Inc is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in Myomo Inc are currently priced at $10.38. At that level they are trading at 73.41% discount to the analyst consensus target price of 0.00.
Analysts covering Myomo Inc currently have a consensus Earnings Per Share (EPS) forecast of -1.928 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Myomo Inc. Over the past six months, the relative strength of its shares against the market has been 92.07%. At the current price of $10.38, shares in Myomo Inc are trading at 40.56% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for Myomo Inc.
Myomo Inc's management team is headed by:
Here are the top five shareholders of Myomo Inc based on the size of their shareholding:
